Challenge for FDA Regulators in a Global Market
Sage Bionetworks - Hyatt Regency
New opportunities for sharing data, including an update on the role of the FDA to build large public disease biology-based clinical and genomic datasets. Approaches will be presented to extend beyond the 2011 pilot project of accessing the “clinical trial comparator arms” of industry clinical trials (CTCAP) and will examine new joint opportunities in regulatory sciences."
